Regulatory News: Year in Review
As 2011 draws to a close, RegBlog reflects back on a year of major regulatory developments around the world. For our daily post today, as well as our posts for the next two days, we will feature the top 50 RegBlog posts of the past twelve months, based on the number of page views. Today we feature, in chronological order, the top news stories from among our top overall posts, while tomorrow and the following day we will feature the top analysis and opinion posts, respectively.
* * *
“Federal Courts Split on Constitutionality of Individual Mandate in Health Care Law,” by Penn Program on Regulation (February 15)
The 2010 Patient Protection Affordable Care Act calls for the creation of insurance exchanges within each state, bans discrimination against patients with pre-existing conditions, and requires all Americans to purchase some form of health insurance. This last strategy, the individual mandate, has prompted a series of lawsuits by opponents who claim the law exceeds Congress’ authority under the Commerce Clause, which gives the federal government authority over economic activity. They argue that individual decisions not to buy health insurance are forms of inactivity.
“Ongoing Litigation in Human Embyonic Stem Cell Research” by Joel Outten (March 8)
The Obama Administration faces ongoing lawsuits challenging financial support of human embryonic stem cell (hESC) research.
In an effort to protect consumers in the mortgage market from unfair practices involving the compensation of loan originators, the Federal Reserve
has issued a new rule
amending Regulation Z
, which implements the Truth in Lending Act
. The new rule, which will take effect on April 1, 2011, prohibits lenders from compensating mortgage brokers or other loan originators based on a mortgage transaction’s terms and conditions, such as its interest rate, annual-percentage rate and loan-to-value ratio.
RegBlog proudly announces that on April 5th we will be posting to a new, enhanced website that better reflects our extensive reporting and analysis of cutting-edge policy issues.
Some members of Congress are attempting to moderate
the pace of implementation of the Dodd-Frank Act
by seeking to limit appropriations for implementing agencies and by introducing
legislation to amend or repeal parts of the Act.
On his first day as President, Barack Obama announced his administration’s “commitment to creating an unprecedented level of openness in government.” Since then, the Obama Administration has implemented a major Open Government Initiative to increase transparency, participation, and collaboration across the federal government.
Citing undue regulatory burden and uncertainty, President Obama asked
the Environmental Protection Agency
(EPA) on Friday to delay updating ozone standards until 2013. In response, EPA Administrator Lisa Jackson
, while touting the “important” and “significant” steps her agency has taken to address environmental concerns, simply stated
that the EPA “will revisit the ozone standard, in compliance with the Clean Air Act
In response to an alarming report
on the rising use of synthetic stimulants, the Drug Enforcement Administration
(DEA) published a notice
earlier this month announcing its intent to prohibit the possession and sale of three substances
that allegedly cause
psychological effects similar to methamphetamine, cocaine, and LSD.
With the support of nearly every Republican member of the House of Representative, along with about forty Democrats, the House passed a new bill last week that would create new guidelines for the Environmental Protection Agency
(EPA) in setting air pollution standards for industrial boilers, process heaters, and incinerators.